购物车
- 全部删除
- 您的购物车当前为空
GSK-1482160是一种CNS-渗透的P2X7受体负变构调节剂,具有口服活性。P2X7受体参与中枢和外周免疫细胞产生促炎细胞因子,因此GSK-1482160具有研究炎症性疾病的潜力。GSK-1482160具有出色的体外效价(在包括人类在内的多种物种的重组和初始P2X7受体的功能和电生理测试中)和交叉靶标选择性。
GSK-1482160是一种CNS-渗透的P2X7受体负变构调节剂,具有口服活性。P2X7受体参与中枢和外周免疫细胞产生促炎细胞因子,因此GSK-1482160具有研究炎症性疾病的潜力。GSK-1482160具有出色的体外效价(在包括人类在内的多种物种的重组和初始P2X7受体的功能和电生理测试中)和交叉靶标选择性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 118 | 现货 | |
5 mg | ¥ 292 | 现货 | |
10 mg | ¥ 472 | 现货 | |
25 mg | ¥ 953 | 现货 | |
50 mg | ¥ 1,420 | 现货 | |
100 mg | ¥ 2,030 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 323 | 现货 |
产品描述 | GSK-1482160 is a CNS-penetrant negative allosteric modulator of P2X7 receptor with oral activity. The P2X7 receptor is involved in the production of pro-inflammatory cytokines by central and peripheral immune cells, so GSK-1482160 has the potential to study inflammatory diseases. GSK-1482160 shows excellent in vitro potency (in functional and electrophysiological assays at recombinant and naive P2X7 receptors across multiple species including humans) and cross-target selectivity. |
体外活性 | ATP激发的含tau蛋白外泌体分泌活动在初代小鼠微胶质细胞中被GSK-1482160显著抑制,而在神经元或星形胶质细胞中未见此效应[2]。 |
体内活性 | 口服GSK-1482160显著减少了海马区MC1+和Alz50+错误折叠tau的积累,伴随着海马神经元中外泌体标志物Tsg101积累的减少。GSK-1482160同样在体内显著增加了微胶质细胞中Tsg101和CD81的积累,这表明它抑制了P2RX7诱导的微胶质细胞外泌体分泌[2]。 |
分子量 | 334.72 |
分子式 | C14H14ClF3N2O2 |
CAS No. | 1001389-72-5 |
Smiles | CN1[C@@H](CCC1=O)C(=O)NCc1cccc(c1Cl)C(F)(F)F |
存储 | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 90.0 mg/mL (268.9 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容